BTMD

biote Corp.

Healthcare · $58M market cap

Share price

$1.15

close of Oct 3, 2026

Fair value

$5.58

Sticker Price

Payback Price

$2.23

buy price

On Sale

BTMD is On Sale: at $1.15 it trades 49% below its buy price (Payback Price) of $2.23 and 79% below its fair value of $5.58. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 5% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth163.2% a year✓

Equity per share growth—?

Sales growth12.4% a year✓

Free cash flow growth5.7% a year✗

Return on invested capital21.8%✓

Follow BTMD

Get notified when it reaches its buy price of $2.23. Free.

Create a free account

Insider activity

Since Jun 12, 2026: 2 open-market purchases worth $202K and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Purchases

Beer Marc D

Executive Chairman · 2026-08-11

Bought

$25K

Beer Marc D

Executive Chairman · 2026-08-10

Bought

$177K

Other filings

Peterson Robert Charles

Interim CEO · 2026-06-12

Award

$509K

About biote Corp.

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements…

Medical - Care Facilities